Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE)

202518 citationsJournal Articlehybrid Open Access

Authors

Philip Joseph

Álvaro Avezum · Hospital Alemão Oswaldo Cruz

Chinthanie Ramasundarahettige · Hamilton Health Sciences

Prem Mony · St.John's Medical College Hospital

Rita Yusuf · Independent University

Khawar Kazmi · Aga Khan University

Andrzej Szuba · Wroclaw Medical University

Abstract

Globally and in most country income-level groups, the use of medications for secondary CVD prevention has been low, with little improvement over time.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Pharmaceutical Economics and Policy Pharmaceutical Practices and Patient Outcomes

Publication Details

Published in: Journal of the American College of Cardiology

Volume 85, Issue 5, pp. 436-447

DOI: 10.1016/j.jacc.2024.10.121

Field-Weighted Citation Impact: 55.17

Command Palette

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE)

Authors

Abstract

Topics & Keywords

Publication Details